Thiamine

Introduction Overview

Generic Name

thiamine

Brand Name

Vitamin B1

Dosage Form

injectable solution (100 mg/mL), oral tablet (50 mg; 100 mg; 250 mg)

Drug Class

Vitamins

Pharmacokinetics

Absorption:
Thiamine is absorbed primarily in the small intestine through an active, carrier-mediated transport system, which becomes saturated at higher doses, leading to limited absorption efficiency with high oral intake. This vitamin is water-soluble, and its bioavailability can be influenced by gastrointestinal pH, presence of food, and interactions with antithiamine factors such as certain raw fish and tea. In conditions like malabsorption syndromes, chronic alcoholism, or gastrointestinal surgery, absorption is significantly impaired. Oral absorption is typically efficient for therapeutic doses but poor at supratherapeutic levels, necessitating parenteral administration in severe deficiency or critical illness.

Distribution:
After absorption, thiamine is distributed widely in body tissues, especially highly metabolic organs such as the heart, liver, kidneys, and brain. It crosses cell membranes via active transport and is phosphorylated intracellularly into active coenzyme forms, primarily thiamine diphosphate (ThDP). The distribution volume for thiamine is relatively small due to its hydrophilic nature and rapid intracellular uptake. The central nervous system uptake is critical because thiamine acts as a cofactor for several neurological enzymes; however, the blood-brain barrier transport is regulated and may be limited in deficiency states.

Metabolism:
Thiamine is converted intracellularly into active phosphorylated derivatives including thiamine monophosphate (TMP), thiamine diphosphate (ThDP), and thiamine triphosphate (TTP). The predominant and metabolically active form is ThDP, which serves as a coenzyme in carbohydrate metabolism enzymes such as pyruvate dehydrogenase and α-ketoglutarate dehydrogenase. Thiamine metabolism also involves its reversible phosphorylation and dephosphorylation. Thiaminase enzymes found in certain raw fish and bacterial flora can degrade thiamine, causing deficiency if consumed chronically.

Elimination:
Thiamine and its phosphorylated derivatives are water-soluble and eliminated primarily via renal excretion. Excess unphosphorylated thiamine is filtered in the glomeruli and secreted in the renal tubules. The half-life of free thiamine in plasma is approximately 1.5 to 3 hours. Under normal conditions, the body maintains small stores; hence a continuous dietary supply is necessary. Renal clearance can be increased in certain disease states or after high-dose supplementation. Biliary excretion and degradation by gut flora also contribute to thiamine elimination. Clinical implications include potential deficiency during increased losses such as renal dialysis or diuretic therapy.

Dosage Forms

Available Dosage Forms:
Thiamine is available in several dosage forms: injectable solution concentrated at 100 mg/mL used for parenteral administration (intramuscular or intravenous), and oral tablets available in doses of 50 mg, 100 mg, and 250 mg. The injectable form is intended for rapid correction of deficiency states or when oral administration is not feasible due to malabsorption or critical illness. The oral tablet provides convenient dosing for maintenance therapy and prophylaxis.

Dosages for Adults and Adolescents:
- Beriberi: 10 to 20 mg intramuscularly three times daily for up to 2 weeks, followed by oral multivitamin preparations containing 5 to 10 mg daily for one month.
- Thiamine deficiency: 100 mg intravenously with dextrose administration to prevent precipitating heart failure; maintenance dosing typically 50 to 100 mg orally once daily.
- Wernicke's Encephalopathy: Initial 100 mg IV dose, followed by 50 to 100 mg daily IM or IV until a regular, balanced diet is re-established.
- Vitamin/mineral supplementation: 50 to 100 mg orally once daily.

For Neuritis of Pregnancy: 5 to 10 mg IM daily if severe vomiting precludes oral therapy.

For 'Wet' beriberi with myocardial failure: slow IV administration as an emergency treatment.

Dosages for Pediatric Patients:
- Beriberi: 10 to 25 mg IM or IV daily if critically ill; or 10 to 50 mg orally daily for 2 weeks, then 5 to 10 mg orally daily for 1 month; if collapse occurs, 25 mg IV with caution.
- Thiamine deficiency with dextrose administration: 100 mg IV to prevent precipitating heart failure, similar to adult dosing.
- Vitamin supplementation: infants 0.3–0.5 mg orally once a day; children 0.5–1 mg orally once a day.

Specific Patient Populations:
- In kidney disease, dosing adjustments or close monitoring might be necessary due to altered clearance and risk of accumulation with parenteral dosing.
- Pregnant and lactating women should receive thiamine supplementation as needed, with dosage tailored by healthcare provider.
- Alcoholics and patients with malnutrition may require higher doses and parenteral administration for effective replenishment.

Clinical Guidelines:
Treatment must be integrated with appropriate dietary modification to ensure adequate carbohydrate intake and overall nutritional rehabilitation.

Mechanism Of Action

Thiamine, also known as vitamin B1, acts as a crucial coenzyme in several enzymatic reactions involved in carbohydrate metabolism. The primary molecular mechanism centers on its phosphorylated form, thiamine diphosphate (ThDP), which serves as a cofactor for key mitochondrial enzymes including pyruvate dehydrogenase and α-ketoglutarate dehydrogenase complexes. These enzymes catalyze critical steps in the Krebs cycle, thereby facilitating the aerobic production of ATP and maintaining cellular energy homeostasis.

On a cellular level, thiamine facilitates the oxidative decarboxylation of pyruvate to acetyl-CoA, linking glycolysis to the Krebs cycle. This biochemical interaction is vital for efficient energy metabolism, particularly in tissues with high metabolic demand such as muscle, heart, and brain. Additionally, thiamine influences neuronal function by participating in the pentose phosphate pathway through the transketolase enzyme, which is important for nucleic acid synthesis and antioxidant defense.

The clinical implications of thiamine’s mechanism include its role in preventing neurological and cardiovascular disorders caused by deficiency states. Deficient activity of thiamine-dependent enzymes leads to cellular energy failure, accumulation of toxic metabolites, and oxidative stress, underpinning pathologies such as Wernicke's encephalopathy and beriberi. Comparative mechanistic studies highlight that unlike other B vitamins, thiamine directly impacts mitochondrial energy metabolism rather than acting as merely a coenzyme for single enzymatic reactions.

Research evidence from clinical studies demonstrates that thiamine supplementation restores enzymatic activity, improves metabolic function, and alleviates clinical symptoms in deficiency syndromes. The rapid clinical improvement observed with parenteral thiamine administration underscores its critical biochemical role. Furthermore, ongoing investigations explore thiamine’s potential neuroprotective effects beyond deficiency correction, including modulation of oxidative stress and inflammation pathways.

Pharmacological Actions

Acts as a coenzyme for pyruvate dehydrogenase, α-ketoglutarate dehydrogenase, and transketolase enzymes involved in carbohydrate metabolism.
Facilitates ATP production via mitochondrial oxidative decarboxylation reactions essential for energy metabolism.
Supports neuronal function through involvement in the pentose phosphate pathway, contributing to nucleic acid synthesis and antioxidant defense.
Prevents accumulation of pyruvate and lactate by enabling aerobic metabolism, thus avoiding metabolic acidosis.
Enhances myocardial energy metabolism important for cardiac function, particularly in beriberi-induced heart failure.
Stimulates conduction in nervous tissue by maintaining energy-dependent neuronal activities.
Exhibits water-solubility allowing renal excretion, thus requiring continuous dietary replenishment.
Demonstrates favorable safety profile with low toxicity even at high therapeutic doses.
Corrects symptoms attributable to thiamine deficiency such as neuropathy, muscle weakness, and neurological impairment.
Improves metabolic responses when administered alongside glucose in deficient states, preventing precipitated cardiac failure.
Plays a role in oxidative stress modulation by supporting enzymatic reactions that generate reducing equivalents.
Used therapeutically to prevent or treat vitamin B1 deficiency-related disorders including beriberi and Wernicke's encephalopathy.
Rapid onset of action when administered parenterally, suitable for emergency treatment of acute deficiency.
Supports general nutritional status as part of multivitamin and mineral supplementation regimens.
Potential neuroprotective mechanisms under investigation beyond classical deficiency treatment.

Therapeutic Or Clinical Uses

Prevention and treatment of thiamine (vitamin B1) deficiency states
Management of beriberi, including ‘dry’ (neurological) and ‘wet’ (cardiac) forms
Treatment of Wernicke's encephalopathy and prevention of Korsakoff syndrome
Therapeutic supplementation in patients with malnutrition or malabsorption syndromes
Supportive therapy in neuropathies related to thiamine deficiency, including alcoholic neuropathy
Intravenous use in emergency settings to rapidly replenish thiamine stores
Use alongside dextrose administration to prevent precipitating heart failure in patients at risk
Dietary supplementation during pregnancy or lactation with increased nutritional demands
Adjunctive therapy in chronic alcoholism and related nutritional deficiencies
Treatment of neuritis of pregnancy when oral administration is not possible
Support in vitamin and mineral supplementation programs for general health maintenance
Use in pediatric patients for prevention and treatment of deficiency and related conditions
Therapeutic role in certain metabolic encephalopathies linked to impaired carbohydrate metabolism
Exposure prophylaxis in patients receiving parenteral nutrition lacking adequate vitamin content
Potential investigational use in neuroprotective treatment protocols

Side Or Adverse Effects

Allergic reactions including hives, swelling of face, lips, tongue, or throat, difficulty breathing
Blue discoloration of lips indicating possible hypoxia or circulatory compromise
Chest pain and shortness of breath as signs of possible hypersensitivity or cardiovascular reaction
Gastrointestinal bleeding noted by black, bloody, or tarry stools
Hematemesis or vomiting of material resembling coffee grounds indicating upper GI bleeding
Nausea and vomiting following oral or parenteral administration
Feeling of tightness or discomfort in the throat after injection
Excessive sweating and sensation of warmth post administration
Mild rash or pruritus indicative of hypersensitivity reactions
Restlessness or nervousness following dosing
Localized tenderness, pain, or formation of a hard lump at injection sites
Rare anaphylactic reactions necessitating immediate emergency care
Injection site reactions including erythema and swelling
Transient hypotension or flushing following intravenous administration
Very rare neurological symptoms potentially linked to rapid infusion rates

Precautions

Do not use if allergic to thiamine or any component of the formulation
Inform healthcare provider about existing medical conditions prior to administration
Consult physician if taking concurrent prescription, over-the-counter, or herbal medications
Exercise caution in patients with kidney disease due to altered elimination and toxicity risk
Follow dietary recommendations closely as thiamine administration is part of multifactorial treatment
Monitor for signs of hypersensitivity especially after parenteral administration
Pregnant or breastfeeding women should use only under medical supervision
Use caution in pediatric patients; administer injectable doses carefully to prevent adverse effects
Avoid administration of dextrose solutions prior to repletion of thiamine in deficient states
Storage according to guidelines to maintain potency—protect from moisture, heat, and light
Educate patients on adherence to dosing regimen and potential side effects
Do not self-administer injectable thiamine without proper training
Special attention to patients with malnutrition or chronic alcoholism who are at increased risk
Monitor cardiovascular status during IV administration in cases of wet beriberi
Avoid off-label use without professional medical advice

Warnings

Prior allergic reaction to thiamine constitutes an absolute contraindication
Risk of severe allergic or anaphylactic reactions, particularly with injectable forms
Potential for precipitating heart failure if thiamine deficiency is uncorrected before glucose infusion
Injectable thiamine must not be used if solution is discolored or contains particulate matter
Do not exceed recommended doses to prevent adverse effects
Special caution required when using in patients with kidney impairment
Thiamine treatment must be accompanied by dietary intervention to ensure effective correction
Not considered teratogenic, but use in pregnancy requires medical supervision to adjust dosage
Unknown if thiamine passes into breast milk; caution advised during lactation
Avoid delay in treatment of deficiency to prevent permanent neurological damage
Monitor for allergic reactions during first administration, especially intravenously
Patients with severe malnutrition should be closely observed for refeeding syndrome
Not a substitute for treatment of underlying causes of deficiency; comprehensive care required
Advise immediate emergency attention if severe side effects or hypersensitivity occur
Avoid combining with drugs that may antagonize vitamin B1 activity without medical guidance

Contraindication

Known hypersensitivity or allergic reaction to thiamine or any component of the product
Previous anaphylactic reactions to injectable thiamine formulations
Use contraindicated if solution is contaminated, discolored, or contains precipitates
Not indicated for prophylactic use in patients without demonstrated deficiency or risk factors
Avoid use in patients with uncorrected electrolyte imbalances unless properly supervised
Contraindicated as monotherapy for conditions unrelated to thiamine deficiency
Should not be administered to patients with hypersensitivity history to other B vitamins without caution
Not to be used in place of proper treatment for underlying nutritional or metabolic disorders
Avoid use in situations where oral supplementation is feasible and effective
Contraindicated in patients with known thiaminase-rich dietary intake without supplementation
Use is inappropriate when there is no clinical or biochemical evidence of deficiency
Patients with acute allergic reactions or severe skin conditions should avoid administration
Not recommended for self-medication without prescription in injectable form
Contraindicated in individuals with anaphylaxis to parenteral vitamins preparations
Use with caution or avoid combination with agents that interfere with thiamine absorption or action

Drug Interactions

No significant drug-drug interactions reported; generally safe with concurrent medications
Potential decreased absorption when administered with antithiamine factors (e.g., raw fish, tea)
Dextrose-containing intravenous solutions can precipitate acute thiamine deficiency if not co-administered
Possible interaction with diuretics that may increase thiamine excretion
Concomitant use with certain chemotherapeutic agents may increase risk of deficiency
No notable significant interaction with herbal supplements documented but caution advised
Certain antibiotics metabolized via similar pathways may alter vitamin absorption indirectly
Interaction with high-dose vitamin C has not been reported but requires monitoring
No known interference with cytochrome P450 enzymes reducing risk of pharmacokinetic interactions
Elevated doses could potentially alter insulin sensitivity or glucose metabolism
Concurrent use with anticonvulsants linked to altered vitamin levels necessitating monitoring
Potential competition in renal excretion with other water-soluble vitamins or drugs
Caution with agents affecting gastrointestinal pH or motility impacting absorption
No significant interaction with anticoagulants or antiplatelet agents documented
Monitor for altered efficacy of vitamin therapy when combined with multiple nutrient supplements

Preparations Of The Drug

Injectable solution: 100 mg/mL thiamine hydrochloride for intramuscular or intravenous use
Oral tablets: 50 mg, 100 mg, and 250 mg strengths for varying clinical needs
Multivitamin formulations containing 5 to 10 mg of thiamine for maintenance therapy
Combination oral supplements with other B-complex vitamins for nutritional support
Parenteral formulations prepared under sterile conditions for hospital and emergency settings
Over-the-counter oral thiamine supplements available for prophylactic use
Intramuscular preparations designed for rapid correction of acute deficiency
Pharmaceutical-grade products meeting standardized potency and purity requirements
Formulations intended for precise dosing in pediatric and adult patient populations
Vitamin B1 tablets formulated for convenient daily oral administration
Injectable forms with appropriate excipients to minimize irritation and discomfort
Combination vitamin preparations customized for various deficiency syndromes
Educational materials provided with prescription formulations to ensure proper use
Storage recommendations to maintain stability include cool, dry, and light-protected environments
Preparations may vary slightly by manufacturer but adhere to regulatory quality standards